|
|
Updated Friday, February 10, 2012 0:20 am TWN, AP |
| ||||||||||||
Apotex pays Bristol, Sanofi damages in Plavix patent infringement battleApotex Corp., Canada's biggest drugmaker, has paid Bristol-Myers Squibb Co. and Sanofi SA, the two brand-name drugmakers that jointly sell Plavix, US$442.2 million in damages ordered over its improper sales of a generic version of Plavix in 2006. Apotex also paid US$1.26 million in interest on that judgment and another US$900,000 in legal costs. The Plavix patent saga began with patent-challenging litigation in March 2002. It includes an illegal deal to delay sales of generic Plavix, a criminal antitrust investigation by the U.S. Justice Department, the ouster of a former Bristol CEO and an earlier probe over alleged inflation of sales figures. | |||||||||||||